Larkspur Health Acquisition Corp (LSPR) Financials

$22.50

$12.81 (132.20%)

As on 12-Dec-2022 16:00EDT

Market cap

$226 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	2.29	--	--	--	--	--
Gross Profit	-2.29	--	--	--	--	--
Operating Expenses	0.61	--	--	--	--	--
Operating Profit (EBIT)	-1.95	--	--	--	--	--
Other Income	--	--	--	--	--	--
Profit before Tax	-1.50	-0.24	--	--	--	--
Provision for Tax	0.05	--	--	--	--	--
Profit after Tax (Net Income)	-1.55	-0.24	--	--	--	--
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-2.11	-0.32	--	--	--	--

Liabilities ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Shareholder's Funds	-4.16	73.49	--	--	--	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	3.38	3.38	--	--	--	--
Current Liabilities	1.63	0.28	--	--	--	--
Total Liabilities	5.84	77.14	--	--	--	--

Assets ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Non-Current Assets	78.96	75.96	--	--	--	--
Current Assets	0.44	1.18	--	--	--	--
Total Assets	81.02	77.14	--	--	--	--
Total Debt*	--	--	--	--	--	--
Net Current Assets	-1.19	0.90	--	--	--	--

Cashflow ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Cash From Operating Activities	--	-0.57	--	--	--	--
Cash Flow from Investing Activities	--	-101.00	--	--	--	--
Cash from Financing Activities	--	102.81	--	--	--	--
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
ROCE (%)	--	--	--	--	--	--
ROE (%)	--	--	--	--	--	--
ROA (%)	-3.73	--	--	--	--	--
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	--	--	--	--	--	--
Net Profit Growth (%)	--	--	--	--	--	--
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Price / Earnings	--	--	--	--	--	--
Price / Book Value	--	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	--	--	--	--	--	--
Close Price ($)	9.99	--	--	--	--	--
High Price ($)	10.30	--	--	--	--	--
Low Price ($)	--	--	--	--	--	--
Market Cap ($ Cr)	225.66	--	--	--	--	--

Solvency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debt to Equity	--	--	--	--	--	--
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	0.27	4.26	--	--	--	--
Quick Ratio	0.27	--	--	--	--	--
Interest Coverage	-12.71	--	--	--	--	--

Operating Efficiency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.